0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Intermediate versus morning chronotype has lower vascular insulin sensitivity in adults with obesity

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aim

          Chronotype reflects a circadian rhythmicity that regulates endothelial function. While the morning chronotype (MORN) usually has low cardiovascular disease risk, no study has examined insulin action on endothelial function between chronotypes. We hypothesized intermediate chronotypes (INT) would have lower vascular insulin sensitivity than morning chronotype (MORN).

          Materials and Methods

          Adults with obesity were classified per Morningness‐Eveningness Questionnaire (MEQ) as either MORN (n = 27, 22 female, MEQ = 63.7 ± 4.7, 53.8 ± 6.7 years, 35.3 ± 4.9 kg/m 2) or INT (n = 29, 23 female, MEQ = 48.8 ± 6.7, 56.6 ± 9.0 years, 35.7 ± 6.1 kg/m 2). A 120 min euglycaemic‐hyperinsulinaemic clamp (40 mU/m 2/min, 90 mg/dl) was conducted to assess macrovascular insulin sensitivity via brachial artery flow‐mediated dilation (%FMD; conduit artery), post‐ischaemic flow velocity (resistance arteriole), as well as microvascular insulin sensitivity via contrast‐enhanced ultrasound [e.g. microvascular blood volume (perfusion)]. Fasting plasma arginine and citrulline, as well as fasting and clamp‐derived plasma endothelin‐1 and nitrate/nitrite, were assessed as surrogates of vasoconstriction and nitric oxide‐mediated vasodilation. Aerobic fitness (VO 2max) and body composition (dual‐energy X‐ray absorptiometry) were also collected.

          Results

          MORN had a higher VO 2max compared with INT ( p < .01), although there was no difference in fat mass. While fasting FMD was similar between groups, insulin lowered FMD corrected to shear stress and microvascular blood volume in INT compared with MORN after co‐varying for VO 2max (both p ≤ .02). INT also had a lower fasting nitrate ( p = .03) and arginine ( p = .07). Higher MEQ correlated with elevated FMD (r = 0.33, p = .03) and lower post‐ischaemic flow velocity (r = −0.33, p = .03) as well as shear rate (r = −0.36, p = .02) at 120 min.

          Conclusion

          When measured during the morning, INT had a lower vascular insulin sensitivity than MORN. Additional work is needed to understand endothelial function differences among chronotypes to optimize cardiovascular disease risk reduction.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: not found

          A comprehensive definition for metabolic syndrome.

          The metabolic syndrome refers to the co-occurrence of several known cardiovascular risk factors, including insulin resistance, obesity, atherogenic dyslipidemia and hypertension. These conditions are interrelated and share underlying mediators, mechanisms and pathways. There has been recent controversy about its definition and its utility. In this article, I review the current definitions for the metabolic syndrome and why the concept is important. It identifies a subgroup of patients with shared pathophysiology who are at high risk of developing cardiovascular disease and type 2 diabetes. By considering the central features of the metabolic syndrome and how they are related, we may better understand the underlying pathophysiology and disease pathogenesis. A comprehensive definition for the metabolic syndrome and its key features would facilitate research into its causes and hopefully lead to new insights into pharmacologic and lifestyle treatment approaches.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Circadian variation in the frequency of onset of acute myocardial infarction.

            To determine whether the onset of myocardial infarction occurs randomly throughout the day, we analyzed the time of onset of pain in 2999 patients admitted with myocardial infarction. A marked circadian rhythm in the frequency of onset was detected, with a peak from 6 a.m. to noon (P less than 0.01). In 703 of the patients, the time of the first elevation in the plasma creatine kinase MB (CK-MB) level could be used to time the onset of myocardial infarction objectively. CK-MB-estimated timing confirmed the existence of a circadian rhythm, with a three-fold increase in the frequency of onset of myocardial infarction at peak (9 a.m.) as compared with trough (11 p.m.) periods. The circadian rhythm was not detected in patients receiving beta-adrenergic blocking agents before myocardial infarction but was present in those not receiving such therapy. If coronary arteries become vulnerable to occlusion when the intima covering an atherosclerotic plaque is disrupted, the circadian timing of myocardial infarction may result from a variation in the tendency to thrombosis. If the rhythmic processes that drive the circadian rhythm of myocardial-infarction onset can be identified, their modification may delay or prevent the occurrence of infarction.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A Biometric Study of Human Basal Metabolism

                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                Journal
                Diabetes, Obesity and Metabolism
                Diabetes Obesity Metabolism
                Wiley
                1462-8902
                1463-1326
                May 2024
                January 21 2024
                May 2024
                : 26
                : 5
                : 1582-1592
                Affiliations
                [1 ] Rutgers University New Brunswick New Jersey USA
                [2 ] Division of Endocrinology, Metabolism &amp; Nutrition Rutgers University New Brunswick New Jersey USA
                [3 ] New Jersey Institute for Food, Nutrition and Health Rutgers University New Brunswick New Jersey USA
                [4 ] Institute of Translational Medicine and Science Rutgers University New Brunswick New Jersey USA
                [5 ] Virginia Commonwealth University Richmond Virginia USA
                [6 ] Division of Endocrinology and Metabolism, Department of Medicifne University of Virginia Health System Charlottesville Virginia USA
                Article
                10.1111/dom.15456
                39afbd74-5a40-4413-9bef-d657d0537b52
                © 2024

                http://creativecommons.org/licenses/by-nc/4.0/

                History

                Comments

                Comment on this article